Benzinga··PrnewswireIceCure's Cryoablation Wins Independent Validation for Breast Fibroadenomas
IceCure's ProSense cryoablation achieved 92.9% volume reduction in independent breast fibroadenoma study, validating technology for a 63,000-patient annual U.S. market.
ICCMmedical deviceminimally invasive surgery